| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3754029
Max Phase: Preclinical
Molecular Formula: C19H26NO6PS
Molecular Weight: 427.46
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1ccc(S(=O)(=O)N(Cc2ccccc2)C(CC(C)C)P(=O)(O)O)cc1
Standard InChI: InChI=1S/C19H26NO6PS/c1-15(2)13-19(27(21,22)23)20(14-16-7-5-4-6-8-16)28(24,25)18-11-9-17(26-3)10-12-18/h4-12,15,19H,13-14H2,1-3H3,(H2,21,22,23)
Standard InChI Key: FCPKYFRIWUQEDW-UHFFFAOYSA-N
Associated Targets(Human)
Matrix metalloproteinase 8 1942 Activities
Matrix metalloproteinase 9 6779 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Matrix metalloproteinase 13 4133 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Matrix metalloproteinase-2 6627 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 427.46 | Molecular Weight (Monoisotopic): 427.1218 | AlogP: 3.44 | #Rotatable Bonds: 9 |
| Polar Surface Area: 104.14 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 1.48 | CX Basic pKa: | CX LogP: 2.98 | CX LogD: 0.58 |
| Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.59 | Np Likeness Score: -0.71 |
References
| 1. Beutel B, Daniliuc CG, Riemann B, Schäfers M, Haufe G.. (2016) Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography., 24 (4): [PMID:26810711] [10.1016/j.bmc.2016.01.017] |
Source
Source(1):